An 8-year-old female presents to the emergency department (ED) referred by her primary care provider (PCP) for left-sided neck swelling and murmur. Per patient’s mother, the patient has had left-sided neck swelling for 1 month. The patient also experienced subjective fevers, chills, headache, and malaise. Over that same period, mom also noticed about 5 pounds of weight loss and intermittent side pain. Because of these concerns, mom took her daughter to the PCP 2 weeks before ED presentation and was diagnosed with lymphadenitis and started on oral amoxicillin-clavulanic acid and told to follow-up the following week. At the following visit, there was a minimal improvement of the neck swelling, so the patient was switched to oral clindamycin. After a week of being on the clindamycin, the patient presented again to the PCP with minimal improvement of her symptoms. At this visit, the PCP also noticed a new cardiac murmur. Because the patient had failed outpatient antibiotic therapy and had this new heart murmur, the PCP referred the patient to the ED.
On arrival to the ED, the patient had appropriate vital signs for her age other than a blood pressure of 169/96. On physical exam, the patient was noted to have a grade 2/6 systolic heart murmur without evidence of radiation. She denies any symptoms of lightheadedness, syncope, palpitations, or fatigue with exertion. Mom states that the patient never had any heart problems nor was there significant family history. The other significant findings on the physical exam was a firm, yet mobile 2-cm mass slightly superior to the left anterior cervical lymphatic chain as well as a weak left radial and brachial pulse.
Differential diagnosis includes, but is not limited to:
Lab workup included:
Laboratory testing including HIV, EBV, TB, blood, urine and throat cultures were all negative.
ESR and CRP were elevated at 72 and 11.7. Blood count was unremarkable and metabolic panel was notable for hypokalemia to 3.1.
Diagnostic imaging included:
Ultrasound of neck showed wall thickening of the left common carotid artery with possible involvement of the left internal carotid artery.
The ECHO was notable for a bicuspid aortic valve, as well as a mildly dilated left ventricle with mildly decreased left ventricular function.
MRI/MRA revealed large vessel vasculitis involving left external carotid artery, left renal artery, superior mesenteric artery, and left subclavian artery.
With the combination of hypertension, a dilated left ventricle, and multiple areas of vasculitis, the diagnosis of Takayasu arteritis was made. The neck mass was likely secondary to vasculitis involving the left carotid artery. Given the physical exam findings, elevated inflammatory markers, multiple cardiac findings, and hypertension, cardiology was consulted, and the patient was admitted.
In the ED, nifedipine was given once for hypertension, and her blood pressure responded appropriately. The patient also had a 4/5 a headache that was treated with Tylenol and Motrin, and it improved. Nephrology was consulted. The specialist recommended a renal ultrasound and other labs as well as starting amlodipine 5 mg daily. The patient was admitted to the hospital for further management.
The patient was started on nifedipine (calcium channel blocker, anti-hypertensive) for her hypertension and then ultimately discharged on carvedilol. Furthermore, for coagulation prophylaxis, she was started on low-dose aspirin due to arteritis involving the left common carotid and vertebral artery.
Rheumatology was also consulted and recommended to start low-dose steroids and mycophenolic acid to help decrease the amount of arterial inflammation.
Nephrology was also consulted in conjunction with cardiology for blood pressure management. In addition to starting anti-hypertensive medications, she was placed on daily fluid restriction.
Takayasu arteritis is a condition in which pathogenesis is poorly understood. It is believed that pathological infiltration of inflammatory cells in the aorta and its different luminal layers and branches are the underlying mechanisms for this disease. This inflammatory process eventually leads to dilation, occlusion, or stenosis of the affected vessel, which can all present in a variety of clinical manifestations.
Takayasu arteritis is a chronic disease with many episodes of exacerbations and remissions of the inflammatory processes. Adult women are primarily affected as they represent 80% to 90% of cases. This disease onset is between 10 to 40 years old, and the diagnosis of Takayasu arteritis tends to be delayed due to the sub-acute onset of symptoms in this disease. This can sometimes lead to worsening progression of disease in this asymptomatic period.
Since the pathophysiology can affect the vessels in different ways, patients can present with a wide array of clinical symptoms. Non-specific findings such as fever, fatigue, and malaise can be the only symptoms present early in the course of this disease. Other common signs and symptoms include weak peripheral pulses, hypertension, limb claudication, gastrointestinal (GI) symptoms, and murmurs.
Histology shows infiltration of predominantly lymphocytes, histiocytes, macrophages, and plasma cells in the media of the aorta and its branches. Progressive damage and destruction of the lamina and media can lead to aneurysmal dilation or dense scarring.
The mainstay of treatment for this condition is steroids. Steroids suppress the progression of the disease and can sometimes reverse early complications. Surgery is an option for patients with aneurysms or severe stenosis. The patient can eventually be weaned off of steroids with symptom and inflammatory marker improvement.
|||He Y,Lv N,Dang A,Cheng N, Pulmonary Artery Involvement in Patients with Takayasu Arteritis. The Journal of rheumatology. 2019 May 15; [PubMed PMID: 31092716]|
|||Goel R,Sathish Kumar T,Danda D, Childhood-Onset Takayasu Arteritis (c-TA): Current and Future Drug Therapy. Paediatric drugs. 2019 May 13; [PubMed PMID: 31087279]|
|||Masui S,Yonezawa A,Izawa K,Hayakari M,Asakura K,Taniguchi R,Isa M,Shibata H,Yasumi T,Nishikomori R,Takita J,Matsubara K, Plasma infliximab monitoring contributes to optimize Takayasu arteritis treatment: a case report. Journal of pharmaceutical health care and sciences. 2019; [PubMed PMID: 31073411]|
|||Lanzi S,Calanca L,Borgeat Kaeser A,Mazzolai L, Walking performances and muscle oxygen desaturation are increased after supervised exercise training in Takayasu arteritis: a case report and a review of the literature. European heart journal. Case reports. 2018 Dec; [PubMed PMID: 31020199]|
|||Novikov PI,Zykova AS,Moiseev SV, The modern therapy of systemic vasculitides: perspectives and challenges. Terapevticheskii arkhiv. 2018 Feb 14; [PubMed PMID: 30701763]|
|||Misra DP,Wakhlu A,Agarwal V,Danda D, Recent advances in the management of Takayasu arteritis. International journal of rheumatic diseases. 2019 Jan; [PubMed PMID: 30698358]|
|||Berti A,Dejaco C, Update on the epidemiology, risk factors, and outcomes of systemic vasculitides. Best practice [PubMed PMID: 30527432]|
|||de Graeff N,Groot N,Brogan P,Ozen S,Avcin T,Bader-Meunier B,Dolezalova P,Feldman BM,Kone-Paut I,Lahdenne P,Marks SD,McCann L,Pilkington C,Ravelli A,van Royen A,Uziel Y,Vastert B,Wulffraat N,Kamphuis S,Beresford MW, European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative. Rheumatology (Oxford, England). 2019 Apr 1; [PubMed PMID: 30535249]|